Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hepatitis B
100%
Liver Transplant Recipients
64%
Liver Transplantation
61%
Hepatocellular Carcinoma
57%
Tenofovir
50%
Retrospective Case Series
50%
Fanconi Syndrome
50%
Hepatologist
50%
Iron Deficiency Anemia
50%
Melanoma
50%
Intussusception
50%
Hepatitis B Immunoglobulin
50%
Hepatitis B Virus
50%
Patient Outcomes
50%
Reinfection
42%
Chronic Anemia
25%
Gastrointestinal Tract
25%
Post-liver Transplant
20%
Chronic Intussusception
16%
Overall Survival
14%
Antiretroviral Therapy
14%
Viremic
14%
Death-censored Graft Survival
14%
Hypophosphatemia
12%
Proteinuria
12%
Cardiac Magnetic Resonance Imaging (cMRI)
11%
Computed Tomography Enterography
8%
Exploratory Laparotomy
8%
Small Intestine
8%
Small Fraction
8%
Gastrointestinal Malignancies
8%
Aphthous Ulcer
8%
Colonoscopy
8%
Older Men
8%
Surgical Intervention
8%
Dizziness
8%
Active Bleeding
8%
Esophagogastroduodenoscopy
8%
Elderly Patients
8%
Polypoid Mass
8%
Gastrointestinal Diseases
8%
Nondiagnostic
8%
Varied Presentation
8%
Video Capsule Endoscopy
8%
Metastatic Melanoma
8%
Primary Gastrointestinal Melanoma
8%
Malignant Melanoma
8%
Retrospective Cohort Study
7%
Cirrhosis
7%
Inconvenience
7%
Medicine and Dentistry
Liver Graft
50%
Hepatitis B
50%
Hepatocellular Carcinoma
50%
Fanconi Syndrome
50%
Tenofovir
50%
Melanoma
50%
Intussusception
50%
Hypochromic Anemia
50%
Liver Transplantation
35%
Hepatitis B Virus
18%
Anemia
18%
Proteinuria
12%
Hypophosphatemia
12%
Magnetic Resonance Imaging
9%
Computer Assisted Tomography
9%
Liver Cancer
9%
Glucosuria
6%
Kidney Tubule Disorder
6%
Renal Replacement Therapy
6%
Dizziness
6%
Exploratory Laparotomy
6%
Esophagogastroduodenoscopy
6%
Elderly Patient
6%
Colonoscopy
6%
Capsule Endoscopy
6%
Metastatic Melanoma
6%
Cancer
6%
Gastrointestinal Distress
6%
Aphthous Stomatitis
6%
Awareness
6%
Bleeding
6%
Computed Tomography Enterography
6%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B
100%
Hepatitis B Virus
68%
Immunoglobulin
50%
Fanconi Renotubular Syndrome
50%
Tenofovir
50%
Reinfection
42%
Overall Survival
21%
Survival Rate
14%
Antiviral Therapy
14%
Hypophosphatemia
12%
Proteinuria
12%
Cohort Study
7%
Graft Failure
7%
Liver Cell Carcinoma
7%
Liver Cirrhosis
7%
Chronic Hepatitis B
7%
Glucosuria
6%
Replacement Therapy
6%
Kidney Tubule Disorder
6%
